
New injectable to treat complex, antibiotic-resistant UTIs now in India. All about plazomicin
New Delhi: A novel antibiotic for managing complicated Urinary Tract Infections (cUTIs)—which often lead to hospitalisation and even death in certain cases due to antimicrobial resistance (AMR)—has been launched in India by Mumbai-based pharma major Cipla. …